Atreca (BCEL) News Today $0.09 0.00 (0.00%) (As of 09/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period August 20, 2024 | seekingalpha.comBicycle Therapeutics Is Looking Increasingly AttractiveApril 23, 2024 | ca.finance.yahoo.comAtreca, Inc. (BCEL) Stock Price, News, Quote & History - Yahoo FinanceApril 21, 2024 | nz.finance.yahoo.comAtreca, Inc. (0C1.MU)February 18, 2024 | wsj.comAtreca Inc. Cl AFebruary 15, 2024 | benzinga.comAtreca Stock (NASDAQ:BCEL), Short Interest ReportFebruary 7, 2024 | msn.comAtreca Inc Announces Executive Departures and Consulting AgreementsDecember 29, 2023 | bizjournals.comImmunome to buy assets from California biotech companyDecember 26, 2023 | tmcnet.comBCEL Stock Alert: Halper Sadeh LLC Is Investigating Atreca, Inc.December 26, 2023 | marketbeat.comTrading was temporarily halted for "BCEL" at 08:12 AM with a stated reason of "News pending."December 21, 2023 | thestreet.comAtreca Inc.December 11, 2023 | benzinga.comAtreca Stock (NASDAQ:BCEL) Dividends: History, Yield and DatesNovember 16, 2023 | morningstar.comAtreca Inc Class A BCELNovember 14, 2023 | marketwatch.comAtreca to Cut About 40% of WorkforceNovember 14, 2023 | finance.yahoo.comAtreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic AlternativesNovember 2, 2023 | es.investing.comAtreca Inc (BCEL)October 24, 2023 | finance.yahoo.comBAKER BROS. ADVISORS LP Reduces Stake in Atreca IncOctober 12, 2023 | benzinga.comWhat's Going On With Atreca Inc Stock?October 12, 2023 | bizjournals.comMid-Peninsula building rode biotech's boom. Now it's showing how to survive the bustSeptember 21, 2023 | finance.yahoo.comAtreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb CrossAugust 11, 2023 | msn.comHC Wainwright & Co. Downgrades Atreca Inc - (BCEL)August 11, 2023 | msn.comStifel Downgrades Atreca Inc - (BCEL)August 11, 2023 | finance.yahoo.comAtreca Reports Second Quarter 2023 Financial Results and Announces Corporate RestructuringAugust 2, 2023 | msn.comAtreca Inc - (BCEL) Price Target Increased by 11.89% to 10.20June 20, 2023 | msn.comAtreca Approaches A Major Go/No-Go DecisionJune 6, 2023 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on Atreca (BCEL)June 5, 2023 | msn.comHC Wainwright & Co. Reiterates Atreca Inc - (BCEL) Buy RecommendationJune 5, 2023 | finance.yahoo.comAtreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual MeetingJune 5, 2023 | markets.businessinsider.comAtreca (BCEL) Gets a Buy from H.C. WainwrightJune 2, 2023 | fool.comAtreca (NASDAQ: BCEL)May 30, 2023 | markets.businessinsider.comStifel Nicolaus Sticks to Their Buy Rating for Atreca (BCEL)May 17, 2023 | ca.finance.yahoo.comAtreca, Inc. (BCEL) Interactive Stock Chart - Yahoo FinanceMay 14, 2023 | ca.finance.yahoo.comAtreca, Inc. (BCEL) Stock Historical Prices & Data - Yahoo FinanceMay 12, 2023 | msn.comHC Wainwright & Co. Reiterates Atreca, Inc. (BCEL) Buy RecommendationMay 11, 2023 | msn.comStifel Maintains Atreca, Inc. (BCEL) Buy RecommendationMay 11, 2023 | finanznachrichten.deAtreca, Inc.: Atreca Reports First Quarter 2023 Financial Results and Recent Corporate DevelopmentsMay 11, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Atreca (BCEL) and Oscar Health (OSCR)May 10, 2023 | finance.yahoo.comAtreca Reports First Quarter 2023 Financial Results and Recent Corporate DevelopmentsApril 26, 2023 | finance.yahoo.comAtreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual MeetingApril 13, 2023 | finance.yahoo.comAtreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual ConferenceApril 6, 2023 | finance.yahoo.comHere's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock NowApril 5, 2023 | finance.yahoo.comAre Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?March 23, 2023 | finance.yahoo.comAtreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023March 21, 2023 | investing.comAtreca (BCEL) Earnings Dates & ReportsMarch 1, 2023 | finance.yahoo.comAtreca to Participate at Cowen’s 43rd Annual Health Care ConferenceFebruary 6, 2023 | finance.yahoo.comAtreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor TargetJanuary 9, 2023 | finance.yahoo.comAtreca Appoints Philippe Bishop, MD as Chief Medical OfficerNovember 10, 2022 | finance.yahoo.comAtreca Reports Third Quarter 2022 Financial Results and Provides Pipeline UpdateOctober 5, 2022 | globenewswire.comAtreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewswireOctober 5, 2022 | finance.yahoo.comAtreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual MeetingSeptember 13, 2022 | streetinsider.comImmPACT Bio Names Jonathan Benjamin, M.D., Ph.D. as Chief Medical Officer - StreetInsider.com Get Atreca News Delivered to You Automatically Sign up to receive the latest news and ratings for BCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Your Ticket to the Future $75B Air Mobility Market Boom? (Ad)Looking for the next big investment opportunity? This company could be your chance to catch the electric aviation wave. Explore their Financial Opportunity Today BCEL Media Mentions By Week BCEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCEL News Sentiment▼0.000.44▲Average Medical News Sentiment BCEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCEL Articles This Week▼00▲BCEL Articles Average Week Get Atreca News Delivered to You Automatically Sign up to receive the latest news and ratings for BCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TRIB News Today INDP News Today FLGC News Today LGVN News Today ONCT News Today ADXN News Today GLTO News Today RWOD News Today PPBT News Today TENK News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCEL) was last updated on 9/11/2024 by MarketBeat.com Staff From Our PartnersPreferred Stock Offer: Get an 8% dividend yield opportunity on this robotics stockThis company, known for its autonomous robotic surgical systems, completed a crowd-funded public offering and ...Deal Maker | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredRecently listed NASDAQ firm is well positioned for growth with game-changing AI platform for e-commerce.With an innovative AI platform, one tiny but growing NASDAQ firm is ushering in a new e-commerce era and is tr...Smallcaps Daily | SponsoredYour Ticket to the Future $75B Air Mobility Market Boom?Looking for the next big investment opportunity? This company could be your chance to catch the electric aviat...Market JAR | SponsoredPlace this $0.99 trade BEFORE the electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredNatural is heading to the NasdaqNatural solutions are already better for the environment. But there’s one company taking it a step further: Th...MedX | SponsoredHow to grow a small trading account into a $100k? Why is Warren Buffett dumping stocks? Billionaires like Warren Buffett, Tim Cook, and Jeff Bezos are offloa...Timothy Sykes | SponsoredWarning For Nvidia HoldersHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart mi...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atreca, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atreca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
